HIGH DENSITY LIPOPROTEIN CHOLESTEROL AS A PREDICTOR OF CARDIOVASCULAR DISEASE MORTALITY IN MEN AND WOMEN: THE FOLLOW-UP STUDY OF THE LIPID RESEARCH CLINICS PREVALENCE STUDY
Abstract
With data from the Lipid Research Clinics Prevalence Study used as a baseline, an average of 8.4 years of mortality follow-up has been completed for 8,825 male and female participants who were at least 30 years of age at the time of the study. The participants were examined at 10 North American sites during 1972-1976. Univariate findings for high density lipoprotein (HDL) cholesterol in the 7,569 persons initially free of coronary heart disease indicate an inverse relation with cardiovascular disease mortality for men and women. Controlling for age, low density lipoprotein (LDL) cholesterol, triglycerides, body mass index, systolic blood pressure, and smoking, multivariate analysis results indicate inverse relations between HDL cholesterol and cardiovascular disease mortality. In men, the cardiovascular disease mortality rate ratio for HDL cholesterol increments of 10 mg/dl was similar to the cardiovascular disease mortality rate ratio for LDL cholesterol increments of 30 mg/dl. In women, HDL cholesterol is more closely related to cardiovascular disease than is LDL cholesterol. HDL cholesterol is inversely related to both coronary heart disease and other cardiovascular disease mortality in both sexes, though the relation of HDL cholesterol with coronary heart disease mortality in women approached statistical significance only for the combined end point of suspect and definite cases. No relation was observed in either sex group between HDL cholesterol and noncardiovascular disease mortality. This study, only the second large prospective study evaluating the role of HDL cholesterol in women, confirms both the importance and the independence in both men and women of HDL cholesterol in the epidemiology of coronary heart disease and other cardiovascular disease mortality.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In epidemiological studies, HDL-cholesterol levels are inversely related to the risk of CHD.
“In epidemiological studies, HDL-cholesterol levels are inversely related to the risk of CHD (40)”
From Effects of low-carbohydrate diets<i>v</i>. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials (2016) · cites this paper as [40]
Cited by
Sorted by citations
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320 · see citing works
Rimm, E. B., Williams, P., Fosher, K., Criqui, M., & Stampfer, M. J. (1999) · BMJ · doi:10.1136/bmj.319.7224.1523 · Cited by 1,360 · see citing works
Self-citationChapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227 · see citing works
Wada, K., Tanaka, K., & Nakashima, K. (2011) · PubMed · Cited by 1,132 · see citing works
Jousilahti, P., Vartiainen, E., Tuomilehto, J., & Puska, P. (1999) · Circulation · doi:10.1161/01.cir.99.9.1165 · Cited by 890 · see citing works
Prospective Studies Collaboration, & Kromhout, D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92836-7 · Cited by 851 · see citing works
Report of the Conference on Low Blood Cholesterol: Mortality Associations.
Jacobs, D. R., Blackburn, H., HIGGINS, M. W., REED, D. M., Iso, H., McMillan, G. C., Neaton, J. D., Nelson, J., Potter, J., & Rifkind, B. M. (1992) · Circulation · doi:10.1161/01.cir.86.3.1046 · Cited by 718 · see citing works
Self-citationNon–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality
Cui, Y. A., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., LANGENBERG, P. W., Bachorik, P. S., & Bush, T. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1413 · Cited by 657 · see citing works
“The cause of death for those identified before November 14, 1987, was determined by a mortality-classification panel after review of relevant documents.(19) The cause of death for those identified after November 14, 1987, was determined by trained nosologists from death certificates obtained using the National Death I…”
MethodSex Differences in Coronary Heart Disease
Barrett-Connor, E. L. (1997) · Circulation · doi:10.1161/01.cir.95.1.252 · Cited by 648 · see citing works
Androgens in Men — Uses and Abuses
Bagatell, C. J., & Bremner, W. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341107 · Cited by 463 · see citing works
The Primary Prevention of Myocardial Infarction
Manson, J. E., Tosteson, H., Ridker, P. M., Satterfield, S., Hebert, P., O'Connor, G. T., Buring, J. E., & Hennekens, C. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205213262107 · Cited by 504 · see citing works
Mansoor, N., Vinknes, K. J., Veierød, M. B., & Retterstøl, K. (2016) · British Journal of Nutrition · doi:10.1017/s0007114515004699 · Cited by 439 · see citing works
Plasma Triglyceride Level and Mortality from Coronary Heart Disease
Criqui, M. H., HEISS, G. M., Cohn, R. D., Cowan, L. D., Suchindran, C., Bangdiwala, S. I., Kritchevsky, S., Jacobs, D. R., O'Grady, H. K., & DAVIS, C. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281702 · Cited by 418 · see citing works
Self-citationGodsland, I. F., Crook, D., Simpson, R., Proudler, T., Felton, C., Lees, B., Anyaoku, V., Devenport, M., & Wynn, V. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232003 · Cited by 417 · see citing works
The Primary Prevention of Coronary Heart Disease in Women
Rich-Edwards, J. W., Manson, J. E., Hennekens, C. H., & Buring, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506293322607 · Cited by 382 · see citing works
High density lipoproteins and coronary heart disease
Barter, P. J., & Rye, K.-A. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05675-0 · Cited by 377 · see citing works
The benefits and risks of testosterone replacement therapy: a review
Morley, J. E. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3025 · Cited by 375 · see citing works
Poulter, N. R., Wedel, H., Dahlöf, B., Sever, P. S., Beevers, D. G., Caulfield, M., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., Mehlsen, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67186-3 · Cited by 319 · see citing works
Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I
Rye, K., & Barter, P. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000104029.74961.f5 · Cited by 307 · see citing works
Risk factors for coronary heart disease: implications of gender
van Lennep, J. R. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00388-1 · Cited by 295 · see citing works
Laws, A., & Reaven, G. M. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00494.x · Cited by 289 · see citing works
Borba, E. F., & Bonfá, E. (1997) · Lupus · doi:10.1177/096120339700600610 · Cited by 289 · see citing works
Evidence of health benefits of canola oil
Lin, L., Allemekinders, H., Dansby, A., Campbell, L., Durance-Tod, S., Berger, A., & Jones, P. J. H. (2013) · Nutrition Reviews · doi:10.1111/nure.12033 · Cited by 285 · see citing works
Yu, S., Derr, J., Etherton, T., & Kris-Etherton, P. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.5.1129 · Cited by 316 · see citing works
HDL Cholesterol Predicts Coronary Heart Disease Mortality in Older Persons
Corti, M.-C. (1995) · JAMA · doi:10.1001/jama.1995.03530070037026 · Cited by 284 · see citing works
n−3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik
Dewailly, É., Blanchet, C., Lemieux, S., Sauvé, L., Gingras, S., Ayotte, P., & Holub, B. J. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.4.464 · Cited by 275 · see citing works
WATTS, N., Notelovitz, M., CHRYSTIETIMMONS, M., ALLENADDISON, W., Wiita, B., & DOWNEY, L. (1995) · Obstetrics and Gynecology · doi:10.1016/0029-7844(94)00448-m · Cited by 270 · see citing works
van der Valk, M., Kastelein, J. J. P., Murphy, R. L., van Leth, F., Katlama, C., Horban, A., Glesby, M. J., Behrens, G. M. N., Clotet, B., Stellato, R. K., et al. (2001) · AIDS · doi:10.1097/00002030-200112070-00008 · Cited by 251 · see citing works
“This inverse relationship between the level of HDL-c and the risk of developing premature CAD has been a consistent ®nding in a large number of prospective studies, such as the Framingham Heart Study [13,14], the PROCAM Study [15], the Helsinki Heart Study [16] and the Lipid Research Clinics Prevalence Mortality Follo…”
ResultCooney, M. T., Dudina, A., De Bacquer, D., Wilhelmsen, L., Sans, S., Menotti, A., De Backer, G., Jousilahti, P., Keil, U., Thomsen, T., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.02.041 · Cited by 250 · see citing works
Inazu, A., Jiang, X., Haraki, T., Yagi, K., KAMON, N., Koizumi, J., Mabuchi, H., Takeda, R., Takata, K., & Moriyama, Y. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117537 · Cited by 246 · see citing works
Plasma Lipoprotein Levels as Predictors of Cardiovascular Death in Women
Bass, K. M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410190045006 · Cited by 331 · see citing works
High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions
Barter, P. J., Kastelein, J. J. P., Nunn, A. V. W., & Hobbs, R. F. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00006-6 · Cited by 239 · see citing works
The metabolic syndrome and cardiovascular disease
Bonora, E. (2006) · Annals of Medicine · doi:10.1080/07853890500401234 · Cited by 231 · see citing works
“Strong evidence on the contribution of this abnormality in the lipoprotein profile to the risk of CVD came initially from the Framingham Study (58), but other longitudinal surveys confirmed this finding (59,60).”
ResultDavidson, M. H., Ma, P., Stein, E. A., Gotto, A. M., Raza, A. A., Chitra, R., & Hutchinson, H. G. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02226-3 · Cited by 230 · see citing works
Teramoto, T., Sasaki, J., Ueshima, H., Egusa, G., Kinoshita, M., Shimamoto, K., Daida, H., Biro, S., Hirobe, K., Funahashi, T., et al. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e537 · Cited by 238 · see citing works
Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men
Bagatell, C. J., Heiman, J. R., Matsumoto, A. M., Rivier, J., & Bremner, W. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.2.8045977 · Cited by 244 · see citing works
High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men.
Kitamura, A., Iso, H., Naito, Y., Iida, M., Konishi, M., Folsom, A. R., Sato, S., Kiyama, M., Nakamura, M., & Sankai, T. (1994) · Circulation · doi:10.1161/01.cir.89.6.2533 · Cited by 212 · see citing works
Epidemiology of coronary heart disease in women
Bello, N. A., & Mosca, L. J. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2003.08.001 · Cited by 207 · see citing works
Cost and health implications of cholesterol lowering.
Goldman, L., Gordon, D. J., Rifkind, B. M., Hulley, S. B., Detsky, A. S., Goodman, D. W., Kinosian, B. P., & Weinstein, M. C. (1992) · Circulation · doi:10.1161/01.cir.85.5.1960 · Cited by 209 · see citing works
Cardiovascular Effects of Estrogen and Lipid-Lowering Therapies in Postmenopausal Women
Guetta, V., & Cannon, R. O. (1996) · Circulation · doi:10.1161/01.cir.93.10.1928 · Cited by 202 · see citing works
Fruit and vegetable consumption and risk factors for cardiovascular disease
Mirmiran, P., Noori, N., Zavareh, M. B., & Azizi, F. (2009) · Metabolism · doi:10.1016/j.metabol.2008.11.002 · Cited by 200 · see citing works
Low fat‐monounsaturated rich diets containing high‐oleic peanuts improve serum lipoprotein profiles
O’Byrne, D., Knauft, D. A., & Shireman, R. B. (1997) · Lipids · doi:10.1007/s11745-997-0088-y · Cited by 199 · see citing works
Bebb, R. A., Anawalt, B. D., Christensen, R. B., Paulsen, C. A., Bremner, W. J., & Matsumoto, A. M. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636300 · Cited by 224 · see citing works
Estrogen and Progestin Compared with Simvastatin for Hypercholesterolemia in Postmenopausal Women
Darling, G. M., Johns, J., McCloud, P., & Davis, S. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370903 · Cited by 189 · see citing works
Esrey, K. L., Joseph, L., & Grover, S. A. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00066-6 · Cited by 184 · see citing works
Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives
Chapman, M. J. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00156-4 · Cited by 181 · see citing works
“An independent, inverse relationship exists between HDL-C concentration and risk of CAD [6,7,38–41].”
BackgroundSattler, K., & Levkau, B. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp070 · Cited by 174 · see citing works
Diagnostic Criteria for Dyslipidemia
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17152 · Cited by 168 · see citing works
Moriyama, Y., Okamura, T., Inazu, A., Doi, M., Iso, H., Mouri, Y., Ishikawa, Y., Suzuki, H., Iida, M., Koizumi, J., et al. (1998) · Preventive Medicine · doi:10.1006/pmed.1998.0340 · Cited by 170 · see citing works
Androgenic Anabolic Steroid Abuse and the Cardiovascular System
Vanberg, P., & Atar, D. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-79088-4_18 · Cited by 162 · see citing works
Epidemiologic aspects of lipid abnormalities
Criqui, M. H., & Golomb, B. A. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00212-5 · Cited by 158 · see citing works
Self-citationHodson, L., Skeaff, C. M., & Chisholm, W.-A. (2001) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601234 · Cited by 156 · see citing works
“There is increasing evidence of the importance of plasma high density lipoprotein cholesterol as a risk factor that is inversely and independently associated with cardiovascular disease (Castelli et al 1986; Jacobs et al 1990; Miller, 1975).”
BackgroundApolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events
van Lennep, J. E. R., Westerveld, H. T., van Lennep, H. W. O. R., Zwinderman, A. H., Erkelens, D. W., & van der Wall, E. E. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.2408 · Cited by 152 · see citing works
Oestrogen deficiency in men: where are we today?
Faustini‐Fustini, M., Rochira, V., & Carani, C. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400111 · Cited by 147 · see citing works
Zhong, G., Huang, S.-Q., Peng, Y., Wan, L., Wu, Y., Hu, T., Hu, J., & Hao, F. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320914756 · Cited by 138 · see citing works
Li, Z., Lin, L., Wu, H., Yan, L., Wang, H., Yang, H., & Li, H. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.559751 · Cited by 143 · see citing works
Protective effect of high density lipoprotein on endothelium-dependent vasodilatation
Li, X.-P., Zhao, S., Zhang, X., Liu, L., Gao, M., & Zhou, Q. (2000) · International Journal of Cardiology · doi:10.1016/s0167-5273(00)00221-7 · Cited by 133 · see citing works
Drexel, H., Amann, F. W., Beran, J., Rentsch, K., CANDINAS, R., Muntwyler, J., Luethy, A., Gasser, T., & Folláth, F. (1994) · Circulation · doi:10.1161/01.cir.90.5.2230 · Cited by 134 · see citing works
Physiologic Testosterone Levels in Normal Men Suppress High-Density Lipoprotein Cholesterol Levels
Bagatell, C. J., Knopp, R. H., Vale, W., Rivier, J. E., & Bremner, W. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-12-967 · Cited by 129 · see citing works
Serum lipid levels in an Iranian adults population: Tehran lipid and glucose study
Azizi, F., Rahmani, M., Ghanbarian, A., Emami, H., Salehi, P., Mirmiran, P., & Sarbazi, N. (2003) · European Journal of Epidemiology · doi:10.1023/a:1023606524944 · Cited by 124 · see citing works
“than in men and that mortality rates from this cause lag behind those of men by about 10 years [59-61].”
BackgroundGENESTJR, J., Bard, J., Fruchart, J., Ordovás, J. M., WILSON, P., & Schaefer, E. J. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90109-g · Cited by 122 · see citing works
Tolani, S., Pagler, T., Murphy, A., Bochem, A., Abramowicz, S., Welch, C., Nagareddy, P., Holleran, S., Hovingh, G., Kuivenhoven, J., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.03.031 · Cited by 119 · see citing works
Bias in relative odds estimation owing to imprecise measurement of correlated exposures
Phillips, A. N., & Smith, G. D. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110712 · Cited by 108 · see citing works
Androgen and progestagen effects on plasma lipids
Bagatell, C. J., & Bremner, W. J. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(95)80016-6 · Cited by 107 · see citing works
Parity and Carotid Artery Atherosclerosis in Elderly Women
Humphries, K. H., Westendorp, I. C. D., Bots, M. L., Spinelli, J. J., Carere, R. G., Albert Hofman, D., & Witteman, J. C. M. (2001) · Stroke · doi:10.1161/hs1001.097224 · Cited by 106 · see citing works
Alcohol consumption and its relation to cardiovascular risk factors in British women.
Razay, G., Heaton, K. W., Bolton, C., & Hughes, A. (1992) · BMJ · doi:10.1136/bmj.304.6819.80 · Cited by 105 · see citing works
Crook, D., Godsland, I. F., Hull, J., & Stevenson, J. C. (1997) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1997.tb11457.x · Cited by 104 · see citing works
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E. A. A., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(11)70033-2 · Cited by 105 · see citing works
Systemic lupus erythematosus and “lupus dyslipoproteinemia”
de Carvalho, J. F., Bonfá, E., & Borba, E. F. (2007) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.11.016 · Cited by 99 · see citing works
Risk factors for cardiovascular disease in women.
Schenck-Gustafsson, K. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.02.014 · Cited by 51 · see citing works
Effects of Exercise Training on Abdominal Obesity and Related Metabolic Complications
Buemann, B., & Tremblay, A. (1996) · Sports Medicine · doi:10.2165/00007256-199621030-00004 · Cited by 99 · see citing works
Bloomfield, H. E., Robins, S. J., Iwane, M. K., Boden, W. E., Elam, M. B., Fye, C. L., Gordon, D. J., Schaefer, E. J., Schectman, G., & Wittes, J. T. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90708-k · Cited by 99 · see citing works
Johannsen, T. H., Kamstrup, P. R., Andersen, R. V., Jensen, G. B., Sillesen, H. H., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1342 · Cited by 98 · see citing works
Menopause and hormone replacement therapy: An overview
HAMMOND, C. (1996) · Obstetrics and Gynecology · doi:10.1016/0029-7844(95)00429-7 · Cited by 97 · see citing works
Update on cardiovascular disease in post-menopausal women
Gorodeski, G. I. (2002) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2002.0282 · Cited by 96 · see citing works
Bagatell, C. J., Knopp, R. H., Rivier, J., & Bremner, W. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.4.8157711 · Cited by 97 · see citing works
Sirniö, P., Väyrynen, J. P., Klintrup, K., Mäkelä, J. T., Mäkinen, M. J., Karttunen, T. J., & Tuomisto, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-05415-9 · Cited by 86 · see citing works
Alcohol and cardiovascular disease
Rimm, E. B. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0054-8 · Cited by 92 · see citing works
Relationship of Endogenous Sex Hormones to Lipids and Blood Pressure in Mid-Aged Women
SHELLEY, J. M., Green, A. C., Smith, A. M. A., Dudley, E., Dennerstein, L., Hopper, J. L., & Burger, H. (1998) · Annals of Epidemiology · doi:10.1016/s1047-2797(97)00123-3 · Cited by 90 · see citing works
Walden, C. E., Retzlaff, B. M., Buck, B. L., McCann, B. S., & Knopp, R. H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.2.375 · Cited by 87 · see citing works
Diet and heart disease. The role of fat, alcohol, and antioxidants.
Gaziano, J., & Manson, J. E. (1996) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70261-7 · Cited by 100 · see citing works
Kärkkäinen, M., Oka, T., Olkkonen, V. M., Metso, J., Hattori, H., Jauhiainen, M., & Ehnholm, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112247200 · Cited by 87 · see citing works
Stent as a Novel Technology for Coronary Artery Disease and Their Clinical Manifestation
Ullah, M., Wahab, A., Khan, S. U., Zaman, U., Rehman, K. U., Hamayun, S., Naeem, M., Ali, H. H. M., Riaz, T., Saeed, S., et al. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101415 · Cited by 85 · see citing works
Insulin resistance and risk factors for coronary heart disease
Laws, A., & Reaven, G. M. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80245-9 · Cited by 87 · see citing works
Gender differences in myocardial blood flow dynamics
Duvernoy, C. S., Meyer, C. G., Seifert‐Klauss, V., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00575-0 · Cited by 85 · see citing works
Osono, Y., Woollett, L. A., Marotti, K. R., Melchior, G. W., & Dietschy, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4114 · Cited by 83 · see citing works
Gorodeski, G. I. (1994) · Experimental Gerontology · doi:10.1016/0531-5565(94)90017-5 · Cited by 83 · see citing works
Reconstituted High-density Lipoprotein Therapy Improves Survival in Mouse Models of Sepsis
Tanaka, S., Genève, C., Zappella, N., Yong-Sang, J., Planesse, C., Louedec, L., Viranaïcken, W., Bringart, M., Montravers, P., Denamur, É., et al. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003155 · Cited by 73 · see citing works
Association of Triglyceride–to–HDL Cholesterol Ratio With Heart Rate Recovery
Shishehbor, M. H., Hoogwerf, B. J., & Lauer, M. S. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.936 · Cited by 80 · see citing works
Jungner, I., Walldius, G., Holme, I., Kolar, W., & Steiner, E. (1992) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02591655 · Cited by 80 · see citing works
An Epidemiologist Looks at Hormones and Heart Disease in Women
Barrett-Connor, E. L. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030876 · Cited by 82 · see citing works
Mechanisms of Dyslipoproteinemias in Systemic Lupus Erythematosus
Borba, E. F., de Carvalho, J. F., & Bonfá, E. (2006) · Journal of Immunology Research · doi:10.1080/17402520600876945 · Cited by 81 · see citing works
“Since HDL, levels are known to be inversely related to coronary artery disease (CAD) risk (Gordon et al. 1977; Castelli et al. 1986; Jacobs et al. 1990) this finding is certainly of concern.”
BackgroundCastro‐Perez, J. M., Briand, F., Gagen, K., Wang, S., Chen, Y., McLaren, D. G., Shah, V., Vreeken, R. J., Hankemeier, T., Sulpice, T., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m016410 · Cited by 78 · see citing works
Paramsothy, P., Knopp, R. H., Bertoni, A. G., Blumenthal, R. S., Wasserman, B. A., Tsai, M. Y., Rue, T. C., Wong, N. D., & Heckbert, S. R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.073 · Cited by 80 · see citing works
“Low HDL-C, which is independently associated with HD (4), has an independent association with common IMT only.”
BackgroundLow HDL-C: A secondary target of dyslipidemia therapy
Rosenson, R. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.021 · Cited by 78 · see citing works
Burchfiel, C. M., Laws, A., Benfante, R., Goldberg, R. J., Hwang, L., Chiu, D., Rodríguez, B. L., Curb, J. D., & Sharp, D. S. (1995) · Circulation · doi:10.1161/01.cir.92.6.1430 · Cited by 78 · see citing works
Swiger, K. J., Martin, S. S., Blaha, M. J., Toth, P. P., Nasir, K., Michos, E. D., Gerstenblith, G., Blumenthal, R. S., & Jones, S. R. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000851 · Cited by 77 · see citing works
“could partly explain why, at equivalent concentrations of LDLC, women continue to retain a survival advantage in coronary artery disease outcomes beyond middle age.(7,33) Indeed, in a large sub-analysis of the Women’s Health Study, Mora et al recently showed that women who had a discordantly low LDL particle concentra…”
BackgroundThe influence of age on the association between cholesterol and cognitive function
van Vliet, P., van de Water, W., de Craen, A. J. M., & Westendorp, R. G. J. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.05.004 · Cited by 76 · see citing works
HDL cholesterol and mortality in Finnish men with special reference to alcohol intake.
Paunio, M., Heinonen, O. P., Virtamo, J. R. K., Klag, M. J., Manninen, V., Albanes, D., & Comstock, G. W. (1994) · Circulation · doi:10.1161/01.cir.90.6.2909 · Cited by 77 · see citing works
Testosterone enanthate at a dose of 200 mg/week decreases HDL‐cholesterol levels in healthy men
Meriggiola, M. C., Marcovina, S. M., Paulsen, C. A., & Bremner, W. J. (1995) · International Journal of Andrology · doi:10.1111/ijan.1995.18.5.237 · Cited by 77 · see citing works
- Authors
- JACOBS, D. R., MEBANE, I. L., BANGDIWALA, S. I., CRIQUI, M. H., TYROLER, H. A., & PROGRAM, F. T. L. R. C.
- Affiliations
- University of Minnesota (US)
- National Institutes of Health (US)
- University of North Carolina at Chapel Hill (US)
- University of California San Diego (US)
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-01-01
- Volume
- 131
- Issue
- 1
- Pages
- 32-47
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W1930168886
- Cited by
- 452
- References
- 0
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 6 · 2021: 10 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 6 · 2016: 8 · 2015: 14 · 2014: 9 · 2013: 12 · 2012: 5
- FWCI
- 25.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hv012156-034)
- National Heart, Lung, and Blood Institute (N01-HV32961, N01-HV 12156, N01-HV12169)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- HDL cholesterol, cardiovascular mortality, coronary heart disease mortality, LDL cholesterol, sex differences, cardiovascular risk factors, mortality prediction
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cause of Death, Coronary Disease, Female, Follow-Up Studies, Heart Diseases, Humans, Cholesterol, HDL, Male, Middle Aged, Probability, Sex Factors, Cohort Studies, Prevalence, Multivariate Analysis, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review